指南与共识乳腺病理

ICCR导管原位癌及小叶原位癌变异型与低级别病变病理报告数据集

Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
指南 / 共识 · Histopathology · 2022-08-08

国际癌症报告合作组织(ICCR)发布首个针对导管原位癌(DCIS)、部分小叶原位癌(LCIS)变异型及低级别病变的国际病理报告数据集。该数据集由多学科国际专家小组基于证据综述制定,包含12个核心要素和5个非核心要素,适用于不同发展水平的地区,旨在标准化病理报告并改善患者管理。

要点

  • 数据集涵盖DCIS、多形性和旺炽性LCIS变异型及低级别病变(包裹性乳头状癌、实性乳头状原位癌、Paget病)。
  • 包含12个核心要素(最低报告标准)和5个非核心要素(推荐报告)。
  • 各要素附有临床相关性解释、定义及核心/非核心的判定理由。

核心结论

  • 该首个国际共识数据集将促进DCIS、LCIS变异型及低级别病变的病理报告标准化,加强临床病理沟通,改善患者结局。
  • 广泛采用将有助于国际比较、多国临床试验及全球乳腺疾病管理改善。

研究设计与样本

  • 由ICCR组织多学科国际专家小组制定,基于当前证据综述,采用严谨高效流程开发循证结构化数据集。

主要发现

  • 数据集包含12个核心(必需)要素和5个非核心(推荐)要素,适用于发达和低收入地区。
  • 对存在争议的领域在缺乏证据时采用务实方法处理。
  • 每个要素均提供注释,解释其临床相关性、适用定义及核心/非核心判定理由。

关键数值与推荐

  • 所有核心要素的使用是任何单个病例的最低报告标准。
  • 数据集涵盖DCIS、多形性和旺炽性LCIS变异型以及低级别病变(包裹性乳头状癌、实性乳头状原位癌、Paget病)。

临床怎么用

  • 病理科医生报告DCIS、LCIS变异型及低级别病变时应至少包含全部12个核心要素。
  • 推荐同时报告5个非核心要素以提供更全面信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To describe a new international dataset for pathology reporting of ductal carcinoma in situ (DCIS), variants of lobular carcinoma in situ (LCIS) and low-grade lesions (encapsulated papillary carcinoma, solid papillary carcinoma in situ, Paget's disease) produced by the International Collaboration on Cancer Reporting (ICCR). METHODS AND RESULTS: The ICCR, a global alliance of pathology bodies, uses a rigorous and efficient process for the development of evidence-based, structured datasets for pathology reporting of common cancers. Their aim is to support quality pathology reporting and engender understanding between the breast surgeon, pathologist, and oncologist for optimal and uniform patient management globally. Here we describe the dataset for DCIS, some variants of LCIS (namely the pleomorphic and the florid variants), and low-grade lesions by a multidisciplinary panel of internationally recognized experts. The agreed dataset comprises 12 core (required) and five noncore (recommended) elements suitable for both developed and low-income jurisdictions, derived from a review of current evidence. Areas of contention were addressed using a pragmatic approach in the absence of evidence. Use of all core elements is the minimum reporting standard for any individual case. Commentary is provided, explaining each element's clinical relevance, definitions to be applied where appropriate for the agreed list of value options and the rationale for considering the element as core or noncore. CONCLUSION: This first internationally agreed dataset for DCIS, variants of LCIS, and low-grade lesions reporting will enable their standardization of pathology reporting and enhance clinicopathological communication leading to improved patient outcomes. Widespread adoption will also facilitate international comparisons, multinational clinical trials, and help to improve the management of breast disease globally.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Fox SB, Webster F, Chen CJ, et al. Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2022. PMID: 35869801. doi:10.1111/his.14725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。